Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients

CONCLUSION: Early administration of high-dose enteral vitamin D3 did not provide an advantage over placebo with respect to 90-day mortality or other, nonfatal outcomes among critically ill, vitamin D–deficient patients.